Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market - Global Outlook and Forecast 2021-2027

Publisher Name :
Date: 28-Oct-2021
No. of pages: 91

This report contains market size and forecasts of Dipeptidyl Peptidase-4 (DPP-4) Inhibitors in global, including the following market information:

Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market Revenue, 2016-2021, 2022-2027, ($ millions)

Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market Sales, 2016-2021, 2022-2027, (K MT)

Global top five Dipeptidyl Peptidase-4 (DPP-4) Inhibitors companies in 2020 (%)

The global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors market was valued at 9302.2 million in 2020 and is projected to reach US$ 10140 million by 2027, at a CAGR of 2.2% during the forecast period.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Dipeptidyl Peptidase-4 (DPP-4) Inhibitors manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market, By Type, 2016-2021, 2022-2027 ($ Millions) & (K MT)

Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market Segment Percentages, By Type, 2020 (%)

- Sitagliptin

- Saxagliptin

- Vildagliptin

- Linagliptin

Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market, By Application, 2016-2021, 2022-2027 ($ Millions) & (K MT)

Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market Segment Percentages, By Application, 2020 (%)

- Hospital

- Clinic

- Others

Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions) & (K MT)

Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market Segment Percentages, By Region and Country, 2020 (%)

- North America

- - US

- - Canada

- - Mexico

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- - Nordic Countries

- - Benelux

- - Rest of Europe

- Asia

- - China

- - Japan

- - South Korea

- - Southeast Asia

- - India

- - Rest of Asia

- South America

- - Brazil

- - Argentina

- - Rest of South America

- Middle East & Africa

- - Turkey

- - Israel

- - Saudi Arabia

- - UAE

- - Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Dipeptidyl Peptidase-4 (DPP-4) Inhibitors revenues in global market, 2016-2021 (Estimated), ($ millions)

Key companies Dipeptidyl Peptidase-4 (DPP-4) Inhibitors revenues share in global market, 2020 (%)

Key companies Dipeptidyl Peptidase-4 (DPP-4) Inhibitors sales in global market, 2016-2021 (Estimated), (K MT)

Key companies Dipeptidyl Peptidase-4 (DPP-4) Inhibitors sales share in global market, 2020 (%)

Further, the report presents profiles of competitors in the market, key players include:

- Eli Lilly

- Glaxo Smith Kline

- Boehringer

- Bristol-Myers Squibb

- Pfizer

- AstraZeneca

- Sanofi

- Novo Nordisk

Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market - Global Outlook and Forecast 2021-2027

Table of Contents

1 Introduction to Research & Analysis Reports
1.1 Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Overall Market Size
2.1 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market Size: 2021 VS 2027
2.2 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue, Prospects & Forecasts: 2016-2027
2.3 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales (Consumption): 2016-2027
3 Company Landscape
3.1 Top Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Players in Global Market
3.2 Top Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Companies Ranked by Revenue
3.3 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue by Companies
3.4 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales by Companies
3.5 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Price by Manufacturer (2016-2021)
3.6 Top 3 and Top 5 Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Companies in Global Market, by Revenue in 2020
3.7 Global Manufacturers Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Product Type
3.8 Tier 1, Tier 2 and Tier 3 Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Players in Global Market
3.8.1 List of Global Tier 1 Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Companies
3.8.2 List of Global Tier 2 and Tier 3 Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market Size Markets, 2021 & 2027
4.1.2 Sitagliptin
4.1.3 Saxagliptin
4.1.4 Vildagliptin
4.1.5 Linagliptin
4.2 By Type - Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue & Forecasts
4.2.1 By Type - Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue, 2016-2021
4.2.2 By Type - Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue, 2022-2027
4.2.3 By Type - Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Market Share, 2016-2027
4.3 By Type - Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales & Forecasts
4.3.1 By Type - Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales, 2016-2021
4.3.2 By Type - Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales, 2022-2027
4.3.3 By Type - Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Market Share, 2016-2027
4.4 By Type - Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Price (Manufacturers Selling Prices), 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market Size, 2021 & 2027
5.1.2 Hospital
5.1.3 Clinic
5.1.4 Others
5.2 By Application - Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue & Forecasts
5.2.1 By Application - Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue, 2016-2021
5.2.2 By Application - Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue, 2022-2027
5.2.3 By Application - Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Market Share, 2016-2027
5.3 By Application - Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales & Forecasts
5.3.1 By Application - Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales, 2016-2021
5.3.2 By Application - Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales, 2022-2027
5.3.3 By Application - Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Market Share, 2016-2027
5.4 By Application - Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Price (Manufacturers Selling Prices), 2016-2027
6 Sights by Region
6.1 By Region - Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market Size, 2021 & 2027
6.2 By Region - Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue & Forecasts
6.2.1 By Region - Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue, 2016-2021
6.2.2 By Region - Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue, 2022-2027
6.2.3 By Region - Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Market Share, 2016-2027
6.3 By Region - Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales & Forecasts
6.3.1 By Region - Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales, 2016-2021
6.3.2 By Region - Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales, 2022-2027
6.3.3 By Region - Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Market Share, 2016-2027
6.4 North America
6.4.1 By Country - North America Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue, 2016-2027
6.4.2 By Country - North America Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales, 2016-2027
6.4.3 US Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market Size, 2016-2027
6.4.4 Canada Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market Size, 2016-2027
6.4.5 Mexico Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market Size, 2016-2027
6.5 Europe
6.5.1 By Country - Europe Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue, 2016-2027
6.5.2 By Country - Europe Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales, 2016-2027
6.5.3 Germany Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market Size, 2016-2027
6.5.4 France Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market Size, 2016-2027
6.5.5 U.K. Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market Size, 2016-2027
6.5.6 Italy Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market Size, 2016-2027
6.5.7 Russia Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market Size, 2016-2027
6.5.8 Nordic Countries Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market Size, 2016-2027
6.5.9 Benelux Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market Size, 2016-2027
6.6 Asia
6.6.1 By Region - Asia Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue, 2016-2027
6.6.2 By Region - Asia Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales, 2016-2027
6.6.3 China Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market Size, 2016-2027
6.6.4 Japan Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market Size, 2016-2027
6.6.5 South Korea Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market Size, 2016-2027
6.6.6 Southeast Asia Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market Size, 2016-2027
6.6.7 India Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market Size, 2016-2027
6.7 South America
6.7.1 By Country - South America Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue, 2016-2027
6.7.2 By Country - South America Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales, 2016-2027
6.7.3 Brazil Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market Size, 2016-2027
6.7.4 Argentina Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market Size, 2016-2027
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue, 2016-2027
6.8.2 By Country - Middle East & Africa Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales, 2016-2027
6.8.3 Turkey Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market Size, 2016-2027
6.8.4 Israel Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market Size, 2016-2027
6.8.5 Saudi Arabia Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market Size, 2016-2027
6.8.6 UAE Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market Size, 2016-2027
7 Manufacturers & Brands Profiles
7.1 Eli Lilly
7.1.1 Eli Lilly Corporate Summary
7.1.2 Eli Lilly Business Overview
7.1.3 Eli Lilly Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Major Product Offerings
7.1.4 Eli Lilly Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales and Revenue in Global (2016-2021)
7.1.5 Eli Lilly Key News
7.2 Glaxo Smith Kline
7.2.1 Glaxo Smith Kline Corporate Summary
7.2.2 Glaxo Smith Kline Business Overview
7.2.3 Glaxo Smith Kline Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Major Product Offerings
7.2.4 Glaxo Smith Kline Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales and Revenue in Global (2016-2021)
7.2.5 Glaxo Smith Kline Key News
7.3 Boehringer
7.3.1 Boehringer Corporate Summary
7.3.2 Boehringer Business Overview
7.3.3 Boehringer Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Major Product Offerings
7.3.4 Boehringer Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales and Revenue in Global (2016-2021)
7.3.5 Boehringer Key News
7.4 Bristol-Myers Squibb
7.4.1 Bristol-Myers Squibb Corporate Summary
7.4.2 Bristol-Myers Squibb Business Overview
7.4.3 Bristol-Myers Squibb Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Major Product Offerings
7.4.4 Bristol-Myers Squibb Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales and Revenue in Global (2016-2021)
7.4.5 Bristol-Myers Squibb Key News
7.5 Pfizer
7.5.1 Pfizer Corporate Summary
7.5.2 Pfizer Business Overview
7.5.3 Pfizer Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Major Product Offerings
7.5.4 Pfizer Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales and Revenue in Global (2016-2021)
7.5.5 Pfizer Key News
7.6 AstraZeneca
7.6.1 AstraZeneca Corporate Summary
7.6.2 AstraZeneca Business Overview
7.6.3 AstraZeneca Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Major Product Offerings
7.6.4 AstraZeneca Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales and Revenue in Global (2016-2021)
7.6.5 AstraZeneca Key News
7.7 Sanofi
7.7.1 Sanofi Corporate Summary
7.7.2 Sanofi Business Overview
7.7.3 Sanofi Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Major Product Offerings
7.4.4 Sanofi Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales and Revenue in Global (2016-2021)
7.7.5 Sanofi Key News
7.8 Novo Nordisk
7.8.1 Novo Nordisk Corporate Summary
7.8.2 Novo Nordisk Business Overview
7.8.3 Novo Nordisk Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Major Product Offerings
7.8.4 Novo Nordisk Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales and Revenue in Global (2016-2021)
7.8.5 Novo Nordisk Key News
8 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Production Capacity, Analysis
8.1 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Production Capacity, 2016-2027
8.2 Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Production Capacity of Key Manufacturers in Global Market
8.3 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Supply Chain Analysis
10.1 Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Industry Value Chain
10.2 Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Upstream Market
10.3 Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List of Tables
Table 1. Key Players of Dipeptidyl Peptidase-4 (DPP-4) Inhibitors in Global Market
Table 2. Top Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Players in Global Market, Ranking by Revenue (2019)
Table 3. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue by Companies, (US$, Mn), 2016-2021
Table 4. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Share by Companies, 2016-2021
Table 5. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales by Companies, (K MT), 2016-2021
Table 6. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Share by Companies, 2016-2021
Table 7. Key Manufacturers Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Price (2016-2021) & (USD/MT)
Table 8. Global Manufacturers Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Product Type
Table 9. List of Global Tier 1 Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type - Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue, (US$, Mn), 2021 VS 2027
Table 12. By Type - Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue (US$, Mn), 2016-2021
Table 13. By Type - Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue (US$, Mn), 2022-2027
Table 14. By Type - Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales (K MT), 2016-2021
Table 15. By Type - Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales (K MT), 2022-2027
Table 16. By Application - Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue, (US$, Mn), 2021 VS 2027
Table 17. By Application - Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue (US$, Mn), 2016-2021
Table 18. By Application - Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue (US$, Mn), 2022-2027
Table 19. By Application - Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales (K MT), 2016-2021
Table 20. By Application - Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales (K MT), 2022-2027
Table 21. By Region - Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue, (US$, Mn), 2021 VS 2027
Table 22. By Region - Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue (US$, Mn), 2016-2021
Table 23. By Region - Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue (US$, Mn), 2022-2027
Table 24. By Region - Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales (K MT), 2016-2021
Table 25. By Region - Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales (K MT), 2022-2027
Table 26. By Country - North America Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue, (US$, Mn), 2016-2021
Table 27. By Country - North America Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue, (US$, Mn), 2022-2027
Table 28. By Country - North America Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales, (K MT), 2016-2021
Table 29. By Country - North America Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales, (K MT), 2022-2027
Table 30. By Country - Europe Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue, (US$, Mn), 2016-2021
Table 31. By Country - Europe Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue, (US$, Mn), 2022-2027
Table 32. By Country - Europe Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales, (K MT), 2016-2021
Table 33. By Country - Europe Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales, (K MT), 2022-2027
Table 34. By Region - Asia Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue, (US$, Mn), 2016-2021
Table 35. By Region - Asia Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue, (US$, Mn), 2022-2027
Table 36. By Region - Asia Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales, (K MT), 2016-2021
Table 37. By Region - Asia Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales, (K MT), 2022-2027
Table 38. By Country - South America Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue, (US$, Mn), 2016-2021
Table 39. By Country - South America Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue, (US$, Mn), 2022-2027
Table 40. By Country - South America Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales, (K MT), 2016-2021
Table 41. By Country - South America Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales, (K MT), 2022-2027
Table 42. By Country - Middle East & Africa Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue, (US$, Mn), 2016-2021
Table 43. By Country - Middle East & Africa Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue, (US$, Mn), 2022-2027
Table 44. By Country - Middle East & Africa Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales, (K MT), 2016-2021
Table 45. By Country - Middle East & Africa Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales, (K MT), 2022-2027
Table 46. Eli Lilly Corporate Summary
Table 47. Eli Lilly Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Product Offerings
Table 48. Eli Lilly Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2016-2021)
Table 49. Glaxo Smith Kline Corporate Summary
Table 50. Glaxo Smith Kline Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Product Offerings
Table 51. Glaxo Smith Kline Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2016-2021)
Table 52. Boehringer Corporate Summary
Table 53. Boehringer Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Product Offerings
Table 54. Boehringer Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2016-2021)
Table 55. Bristol-Myers Squibb Corporate Summary
Table 56. Bristol-Myers Squibb Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Product Offerings
Table 57. Bristol-Myers Squibb Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2016-2021)
Table 58. Pfizer Corporate Summary
Table 59. Pfizer Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Product Offerings
Table 60. Pfizer Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2016-2021)
Table 61. AstraZeneca Corporate Summary
Table 62. AstraZeneca Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Product Offerings
Table 63. AstraZeneca Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2016-2021)
Table 64. Sanofi Corporate Summary
Table 65. Sanofi Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Product Offerings
Table 66. Sanofi Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2016-2021)
Table 67. Novo Nordisk Corporate Summary
Table 68. Novo Nordisk Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Product Offerings
Table 69. Novo Nordisk Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2016-2021)
Table 70. Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Production Capacity (K MT) of Key Manufacturers in Global Market, 2019-2021 (K MT)
Table 71. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Capacity Market Share of Key Manufacturers, 2019-2021
Table 72. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Production by Region, 2016-2021 (K MT)
Table 73. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Production by Region, 2022-2027 (K MT)
Table 74. Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market Opportunities & Trends in Global Market
Table 75. Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market Drivers in Global Market
Table 76. Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market Restraints in Global Market
Table 77. Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Raw Materials
Table 78. Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Raw Materials Suppliers in Global Market
Table 79. Typical Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Downstream
Table 80. Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Downstream Clients in Global Market
Table 81. Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Segment by Type
Figure 2. Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Segment by Application
Figure 3. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue, 2016-2027 (US$, Mn)
Figure 7. Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales in Global Market: 2016-2027 (K MT)
Figure 8. The Top 3 and 5 Players Market Share by Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue in 2020
Figure 9. By Type - Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Market Share, 2016-2027
Figure 10. By Type - Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Market Share, 2016-2027
Figure 11. By Type - Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Price (USD/MT), 2016-2027
Figure 12. By Application - Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Market Share, 2016-2027
Figure 13. By Application - Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Market Share, 2016-2027
Figure 14. By Application - Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Price (USD/MT), 2016-2027
Figure 15. By Region - Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Market Share, 2016-2027
Figure 16. By Region - Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Market Share, 2016-2027
Figure 17. By Country - North America Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Market Share, 2016-2027
Figure 18. By Country - North America Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Market Share, 2016-2027
Figure 19. US Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue, (US$, Mn), 2016-2027
Figure 20. Canada Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue, (US$, Mn), 2016-2027
Figure 21. Mexico Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue, (US$, Mn), 2016-2027
Figure 22. By Country - Europe Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Market Share, 2016-2027
Figure 23. By Country - Europe Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Market Share, 2016-2027
Figure 24. Germany Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue, (US$, Mn), 2016-2027
Figure 25. France Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue, (US$, Mn), 2016-2027
Figure 26. U.K. Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue, (US$, Mn), 2016-2027
Figure 27. Italy Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue, (US$, Mn), 2016-2027
Figure 28. Russia Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue, (US$, Mn), 2016-2027
Figure 29. Nordic Countries Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue, (US$, Mn), 2016-2027
Figure 30. Benelux Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue, (US$, Mn), 2016-2027
Figure 31. By Region - Asia Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Market Share, 2016-2027
Figure 32. By Region - Asia Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Market Share, 2016-2027
Figure 33. China Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue, (US$, Mn), 2016-2027
Figure 34. Japan Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue, (US$, Mn), 2016-2027
Figure 35. South Korea Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue, (US$, Mn), 2016-2027
Figure 36. Southeast Asia Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue, (US$, Mn), 2016-2027
Figure 37. India Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue, (US$, Mn), 2016-2027
Figure 38. By Country - South America Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Market Share, 2016-2027
Figure 39. By Country - South America Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Market Share, 2016-2027
Figure 40. Brazil Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue, (US$, Mn), 2016-2027
Figure 41. Argentina Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue, (US$, Mn), 2016-2027
Figure 42. By Country - Middle East & Africa Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Market Share, 2016-2027
Figure 43. By Country - Middle East & Africa Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Market Share, 2016-2027
Figure 44. Turkey Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue, (US$, Mn), 2016-2027
Figure 45. Israel Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue, (US$, Mn), 2016-2027
Figure 46. Saudi Arabia Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue, (US$, Mn), 2016-2027
Figure 47. UAE Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue, (US$, Mn), 2016-2027
Figure 48. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Production Capacity (K MT), 2016-2027
Figure 49. The Percentage of Production Dipeptidyl Peptidase-4 (DPP-4) Inhibitors by Region, 2020 VS 2027
Figure 50. Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Industry Value Chain
Figure 51. Marketing Channels
  • Global Metformin Hydrochloride Market Research Report 2024
    Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 104
    Metformin hydrochloride is The raw material of finished product metformin hydrochloride drugs. That is The API metformin hydrochloride. Metformin Hydrochloride finished product is an oral antihyperglycemic drug used in The management of type 2-diabetes. Metformin hydrochloride (N, N-dimethylimidodicarbonimidic diamide hydrochloride) is not chemically or pharmacologically related to any other classes of oral antihyperglycemic agents. Metformin hydrochloride is a white to off-white crystall......
  • Global Antidiabetic Sulphonylureas Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 04-Jan-2024        Price: US 3380 Onwards        Pages: 112
    Market Overview of Global Antidiabetic Sulphonylureas market: According to our latest research, the global Antidiabetic Sulphonylureas market looks promising in the next 5 years. As of 2022, the global Antidiabetic Sulphonylureas market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of t......
  • Global Insulin Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 101
    According to our LPI (LP Information) latest study, the global Insulin market size was valued at US$ million in 2023. With growing demand in downstream market, the Insulin is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report highlights the growth potential of the global Insulin market. Insulin are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization......
  • Global Insulin API Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 116
    According to our LPI (LP Information) latest study, the global Insulin API market size was valued at US$ 1707.6 million in 2023. With growing demand in downstream market, the Insulin API is forecast to a readjusted size of US$ 2101.4 million by 2030 with a CAGR of 3.0% during review period. The research report highlights the growth potential of the global Insulin API market. Insulin API are expected to show stable growth in the future market. However, product differentiation, reducing co......
  • Global Glucagon Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 101
    According to our LPI (LP Information) latest study, the global Glucagon market size was valued at US$ 543.9 million in 2023. With growing demand in downstream market, the Glucagon is forecast to a readjusted size of US$ 835.7 million by 2030 with a CAGR of 6.3% during review period. The research report highlights the growth potential of the global Glucagon market. Glucagon are expected to show stable growth in the future market. However, product differentiation, reducing costs, and suppl......
  • Global Acarbose Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 95
    According to our LPI (LP Information) latest study, the global Acarbose market size was valued at US$ 135.8 million in 2023. With growing demand in downstream market, the Acarbose is forecast to a readjusted size of US$ 165.9 million by 2030 with a CAGR of 2.9% during review period. The research report highlights the growth potential of the global Acarbose market. Acarbose are expected to show stable growth in the future market. However, product differentiation, reducing costs, and suppl......
  • Global Insulin Glargine Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 77
    According to our LPI (LP Information) latest study, the global Insulin Glargine market size was valued at US$ 6562.1 million in 2023. With growing demand in downstream market, the Insulin Glargine is forecast to a readjusted size of US$ 8722.5 million by 2030 with a CAGR of 4.1% during review period. The research report highlights the growth potential of the global Insulin Glargine market. Insulin Glargine are expected to show stable growth in the future market. However, product differen......
  • Global Liraglutide Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 103
    According to our LPI (LP Information) latest study, the global Liraglutide market size was valued at US$ million in 2023. With growing demand in downstream market, the Liraglutide is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report highlights the growth potential of the global Liraglutide market. Liraglutide are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply ch......
  • Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 96
    According to our LPI (LP Information) latest study, the global Glucagon Like Peptide-1 (GLP-1) Agonists market size was valued at US$ 8624.4 million in 2023. With growing demand in downstream market, the Glucagon Like Peptide-1 (GLP-1) Agonists is forecast to a readjusted size of US$ 21310 million by 2030 with a CAGR of 13.8% during review period. The research report highlights the growth potential of the global Glucagon Like Peptide-1 (GLP-1) Agonists market. Glucagon Like Peptide-1 (GL......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs